Article

Complementary Use of a Next-Generation Emollient Plus and Pimecrolimus in Atopic Dermatitis: A Case Report

2023-07-14

Abstract excerpt

Atopic dermatitis (AD) is a chronic skin disease marked by inflammation, erythema, dryness and pruritic lesions. Due to the intermittent nature of the disease, management strategies for AD focus on flare prevention following remission. A 24-year-old patient with mild-to-moderate AD lesions, previously non-responsive to topical corticosteroids (TCS), was treated with pimecrolimus for 12 days and emollient plus crea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 46943ae0-5231-5582-b699-1ccac3b39852
DOI: 10.20944/preprints202307.0971.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Complementary Use of a Next-Generation Emollient Plus and Pimecrolimus in Atopic Dermatitis: A Case ReportDOI 10.20944/preprints202307.0971.v1Read

Japanese guidelines for atopic dermatitis 2017.Semantic proximity Read

Atopic dermatitis: review of immunopathogenesis and advances in immunosuppressive therapy.Semantic proximity Read

Clinical phenotypes of adult atopic dermatitis and related therapies.Semantic proximity Read

Atopic eczema: the current state of clinical research.Semantic proximity Read

Clinical Study of Atopic Dermatitis Treated using the saehim system: A Six-Stage Self-Healing Approach for Atopic Dermatitis and Inflammatory Skin DiseasesSemantic proximity Read

Use of ceramides and related products for childhood-onset eczema.Semantic proximity Read

Natural advances in eczema care.Semantic proximity Read

Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.Semantic proximity Read

Efficacy Trajectory and Hematologic Safety of Oral JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Prospective Real-World StudySemantic proximity Read

Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 PatientsSemantic proximity Read

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.Semantic proximity Read

8th Georg Rajka International Symposium on Atopic Dermatitis: meeting report.Semantic proximity Read